BPC-157 and TB-500 operate through fundamentally different molecular mechanisms: BPC-157 modulates the nitric oxide system and upregulates growth factors including EGF, VEGF, and FGF-2 to promote cytoprotection and angiogenesis, while TB-500 sequesters G-actin monomers to regulate actin polymerization, cytoskeletal dynamics, and cell migration
It is available in several forms, including reduced, liposomal, and precursor variations
These disruptions trigger neuronal malnutrition, structural changes, and functional loss
Tirzepatide (Mounjaro, Zepbound) operates through dual mechanisms, targeting both GLP-1 and GIP receptors for enhanced insulin and glucagon regulation
However, while the final outcome of mitochondrial dysfunction is cell death, the phenotype of death (apoptosis and/or necrosis) depends on the level of cellular ATP, as ATP is required for the efficient assembly of the apoptosome